breast mass

基本解釋

Results The HFU plus CDE diagnose for benign and malignant breast mass accuracy was 90 1% and 88 2%.
結(jié)果高頻超聲結(jié)郃CDE對乳腺良、惡性腫塊的診斷正確率分別爲(wèi)90 .1%和88.2 %。
The correct prompts rate was 70. 5 % in the cases with breast mass, 75. 0 % in the cases with breast microcalcification and 100. 0 % in the cases with breast cancer.
對存在結(jié)節(jié)及微鈣化的圖像提示符郃率（正確率）較高（70．5％及75．0％），對於惡性腫瘤的正確提示率爲(wèi)100％。
Color doppler flow imaging was used to examine the breast mass of 48 patients. It was proved by operation and pathology that 21 cases were benign and 27 cases were malignant.
對48例乳腺腫塊行彩色多普勒血流顯像檢查，經(jīng)手術(shù)和病理証實(shí)，良性腫塊爲(wèi)21例，惡性腫瘤爲(wèi)27例。

This morning, Roche announced that the Food and Drug Administration refused to consider the application for the TDM-1 breast cancer drug based on technology that it licensed from Immunogen, a Waltham, Mass. biotechnology company.
FORBES: Bad News For Immunogen
One of his success stories is 57-year-old breast-cancer surgeon Robert DerHagopian, who started injecting growth hormone a year ago to regain the muscle mass he lost after undergoing surgery for a perforated colon.
FORBES: Sweet Syringe of Youth
One of his success stories is a 57-year-old breast-cancer surgeon, Robert DerHagopian, who started injecting growth hormone a year ago to regain the muscle mass he lost after undergoing surgery for a perforated colon.
FORBES: Sweet syringe of youth

乳腺腫塊
Objective To evaluate the value of three-dimensional ultrasound (3DUS) in the diagnosis of breast masses.
目的探討三維超聲在乳腺腫塊中的應(yīng)用價(jià)值.。